Halozyme Therapeutics Inc (NASDAQ:HALO)

16.35
Delayed Data
As of Sep 16
 +0.07 / +0.43%
Today’s Change
13.24
Today|||52-Week Range
18.76
+11.76%
Year-to-Date

Today’s Trading

Previous close16.28
Today’s open16.15
Day’s range16.09 - 16.46
Volume605,241
Average volume (3 months)839,340
Market cap$2.4B
Data as of 4:00pm ET, 09/16/2019

Growth & Valuation

Earnings growth (last year)-221.61%
Earnings growth (this year)+36.35%
Earnings growth (next 5 years)+55.00%
Revenue growth (last year)-52.04%
P/E ratioNM
Price/Sales13.83
Price/Book9.46

Competitors

 Today’s
change
Today’s
% change
IMMUImmunomedics Inc+0.60+3.59%
XLRNAcceleron Pharma Inc+0.75+1.71%
TLRYTilray Inc-0.86-2.72%
CRSPCRISPR Therapeutics ...+2.00+4.20%
Data as of 4:00pm ET, 09/16/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$151.9M
Annual profit (last year)-$80.3M
Net profit margin-52.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts